ANI Pharmaceuticals | ANIP - Fremdkapital





Fremdkapital Veränderung Datum
AbbVie USD 58.94B 4.03B 2025-12
ANI Pharmaceuticals USD 286M 5.84M 2026-03
Aurora Cannabis CAD 33.2M 1.79M 2025-12
Canopy Growth CAD 224.99M 1.34M 2025-12
Eli Lilly USD 39.37B 1.5B 2026-03
Emergent BioSolutions USD 446.5M 1.7M 2023-12
Heron Therapeutics USD 140.64M 975K 2025-12
Hikma Pharmaceutical USD 1.49B 692M 2025-12
Knight Therapeutics CAD 57.78M 26.92M 2025-12
Nektar Therapeutics USD 63.16M 44.35M 2025-12
Novartis USD 29.59B 5.35B 2025-12
Omeros USD 403.72M 27.2M 2024-06
Perrigo USD 3.62B 17.5M 2026-03
Sun Pharmaceuticals INR 3.93B 309.9M 2026-03
Teva Pharmaceutical Industries USD 14.02B 971M 2026-03